JPWO2021207178A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021207178A5
JPWO2021207178A5 JP2022561651A JP2022561651A JPWO2021207178A5 JP WO2021207178 A5 JPWO2021207178 A5 JP WO2021207178A5 JP 2022561651 A JP2022561651 A JP 2022561651A JP 2022561651 A JP2022561651 A JP 2022561651A JP WO2021207178 A5 JPWO2021207178 A5 JP WO2021207178A5
Authority
JP
Japan
Prior art keywords
silver nanoparticles
use according
nanoparticles
silver
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022561651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521150A5 (https=
JP2023521150A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025942 external-priority patent/WO2021207178A1/en
Publication of JP2023521150A publication Critical patent/JP2023521150A/ja
Publication of JPWO2021207178A5 publication Critical patent/JPWO2021207178A5/ja
Publication of JP2023521150A5 publication Critical patent/JP2023521150A5/ja
Pending legal-status Critical Current

Links

JP2022561651A 2020-04-06 2021-04-06 コロナウイルス感染の阻害および処置に使用するための銀ナノ粒子 Pending JP2023521150A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063005727P 2020-04-06 2020-04-06
US63/005,727 2020-04-06
PCT/US2021/025942 WO2021207178A1 (en) 2020-04-06 2021-04-06 Silver nanoparticles for use in inhibiting and treating coronavirus infection

Publications (3)

Publication Number Publication Date
JP2023521150A JP2023521150A (ja) 2023-05-23
JPWO2021207178A5 true JPWO2021207178A5 (https=) 2024-04-17
JP2023521150A5 JP2023521150A5 (https=) 2024-04-17

Family

ID=78023543

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561651A Pending JP2023521150A (ja) 2020-04-06 2021-04-06 コロナウイルス感染の阻害および処置に使用するための銀ナノ粒子

Country Status (5)

Country Link
US (1) US20230158067A1 (https=)
EP (1) EP4132467A4 (https=)
JP (1) JP2023521150A (https=)
CN (1) CN115551482A (https=)
WO (1) WO2021207178A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250338852A1 (en) * 2022-05-30 2025-11-06 Shin-Etsu Chemical Co., Ltd. Antiviral composition and member having same on surface

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135195B2 (en) * 1999-06-01 2006-11-14 American Silver, Llc Treatment of humans with colloidal silver composition
AU2003304507A1 (en) * 2003-10-16 2005-05-05 Toagosei Co., Ltd. Anti-coronavirus agent
KR20050077887A (ko) * 2004-01-28 2005-08-04 (주)지피엔이 코로나 바이러스 및 인플루엔자 바이러스 등에 억제능이있는 나노무기항균제
US20090191247A1 (en) * 2004-12-06 2009-07-30 Nanotechnologies, Inc Anti-Viral Uses Of Carbon And Metal Nanomaterial Compositions
US20130315972A1 (en) * 2012-05-24 2013-11-28 Agienic, Inc. Compositions and methods for antimicrobial metal nanoparticles
WO2012174466A2 (en) * 2011-06-17 2012-12-20 Annuary Healthcare, Inc. Nanoscale particle formulations and methods
CN102579490A (zh) * 2012-02-22 2012-07-18 大连大学 一种纳米银抗病毒溶液及其制作方法
CN102861102A (zh) * 2012-09-21 2013-01-09 华绣科技有限公司 一种纳米银抑菌喷剂
US20160081346A1 (en) * 2014-09-23 2016-03-24 Attostat, Inc. Antimicrobial compositions and methods
WO2016161348A1 (en) * 2015-04-01 2016-10-06 Attostat, Inc. Nanoparticle compositions and methods for treating or preventing tissue infections and diseases
CN105412379A (zh) * 2015-12-09 2016-03-23 刘传新 一种吸入式治疗肺结核制剂及其制备方法
SI25804A (sl) * 2020-03-19 2020-09-30 Danijela Marković Koloidno srebro za uporabo in postopek njegove priprave

Similar Documents

Publication Publication Date Title
EP2315580B1 (en) Pharmaceutical formulations and methods for treating respiratory tract infections
CA2714286C (en) The use of an acetylsalicylic acid salt for treating viral infections
TR201807714T4 (tr) İnhalasyon tedavisine yönelik nebülize antibiyotikler.
JP2002519318A5 (https=)
JP2774379B2 (ja) 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途
US8709496B2 (en) Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract
JP2008533072A5 (https=)
WO2022111497A1 (zh) 碘在制备预防、治疗呼吸道感染性疾病的药物中的应用
JPWO2021207178A5 (https=)
JP2013539784A (ja) 嚢胞性線維症の吸入デヌホソルでの治療方法
US20240165191A1 (en) Compositions and methods for reducing the transmissivity of illnesses using an oral delivery system
US20230158067A1 (en) Silver nanoparticles for use in inhibiting and treating coronavirus infection
US20210252027A1 (en) Pharmaceutical formulation containing remdesivir
JP2002030000A (ja) 風邪根本治療法
US20220401472A1 (en) Compositions for prevention and treatment of rsv and coronavirus infection
JPH09227373A (ja) 抗インフルエンザウイルス剤
CN101022797B (zh) 具有2-咪唑啉结构的α-拟交感神经药的新用途
US20250049733A1 (en) Pharmaceutical composition for the treatment of infectious respiratory diseases caused by influenza and sars-cov-2, among others
HK40086332A (zh) 用於抑制和治疗冠状病毒感染的银纳米颗粒
US4010269A (en) Antiviral quinazoline compositions and methods of use
CN119894498A (zh) 用于治疗呼吸道感染的药物干粉组合物和方法
WO2026013009A1 (en) Compounds for use in the treatment and prevention of infections with rsv
IT202000012343A1 (it) Metotrexato per l’uso nel trattamento farmaceutico di infezioni virali del tratto respiratorio
JPWO2023114971A5 (https=)